Last edition
News about "US FDA approval for Lastacaft ophthalmic solution"
Alembic Pharma gets US FDA approval for Lastacaft ophthalmic solution
Alembic Pharmaceuticals Limited has received tentative approval from the US Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) alcaftadine ophthalmic solution, 0.25%
US FDA Approval For Lastacaft Ophthalmic Solution | 21/04/2020 | By Darshana | 713
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members